Addition [qlco]    
Effect [qlco]    
blood drugs [phsu]    
Lower [spco]    
Renin-angiotensin system [bdsy]    
Site [spco]    
Cancer Risk [qnco]    
patient [podg]    
Diabetes Type 2 [dsyn]    
Background [cnce]    
Hyperglycaemia [dsyn]    
Associated [qlco]    
Increase [qnco]    
Risk [qlco]    
Site [spco]    
Cancer [neop]    
Mediate [socb]    
Activate [acty]    
Renin-angiotensin system [bdsy]    
<3 [qnco]    
Hydroxy [inch]    
Pathway [moft]    
examinations [fndg]    
Joint [bsoj]    
Associate [menp]    
Optimal [qlco]    
glycemia [carb]    
Control [grup]    
Renin-angiotensin system [bdsy]    
Inhibitor [chvf]    
Hydroxy [inch]    
Inhibitor [chvf]    
Cancer [neop]    
Incidence [qnco]    
patient [podg]    
Diabetes Type 2 [dsyn]    
Method [inpr]    
patient [podg]    
Diabetes Type 2 [dsyn]    
Histories [ocdi]    
Cancer [neop]    
Prior [tmco]    
Exposure NOS [inpo]    
Renin-angiotensin system [bdsy]    
Hydroxy [inch]    
Inhibitor [chvf]    
baseline [bodm]    
Observation [ftcn]    
patient [podg]    
Comprehension [qlco]    
Assess [hlca]    
baseline [bodm]    
followed [tmco]    
Date [tmco]    
Death [orgf]    
Result [ftcn]    
median [spco]    
Follow-up [fndg]    
period [tmco]    
year [tmco]    
Interquartile Range [qnco]    
+2 [qnco]    
patient [podg]    
Site [spco]    
Cancer [neop]    
baseline [bodm]    
patient [podg]    
Incidence [idcn]    
Cancer [neop]    
Old [tmco]    
Long duration [qlco]    
Disease [dsyn]    
Diabetes [dsyn]    
High [qlco]    
ALCOHOL [orch]    
Tobacco use NOS [fndg]    
high systolic blood pressure [fndg]    
Albuminuria [fndg]    
Lower [spco]    
Triglyceride level [lbtr]    
Estimate [qnco]    
Glomerular Filtration Rate [diap]    
patient [podg]    
Cancer [neop]    
Follow-up [fndg]    
less [inpr]    
Likely [qlco]    
Start [qlco]    
Using [ftcn]    
>5 [qnco]    
Cancer [neop]    
free [ftcn]    
Variability [qlco]    
New [tmco]    
treatment [ftcn]    
Hazard Ratio [qnco]    
Confidence Interval [qnco]    
0.014" [qnco]    
31 [inpr]    
Renin-angiotensin system [bdsy]    
Inhibitor [chvf]    
55 [inpr]    
Associated [qlco]    
Reduced [qlco]    
Cancer Risk [qnco]    
patient [podg]    
Three [qnco]    
Risk factor [qnco]    
Non [ftcn]    
use [ftcn]    
Renin-angiotensin system [bdsy]    
Inhibitor [chvf]    
Non [ftcn]    
use [ftcn]    
Four [qnco]    
Fold [spco]    
Adjusted [ftcn]    
High Risk [qlco]    
Cancer [neop]    
Risk factor [qnco]    
Incidence [qnco]    
1+ [qnco]    
Person [popg]    
year [tmco]    
Risk factor [qnco]    
<3 [qnco]    
/40 [tmco]    
One [qnco]    
Risk factor [qnco]    
Two [qnco]    
Risk factor [qnco]    
/40 [tmco]    
6/60 [fndg]    
Three [qnco]    
Risk factor [qnco]    
Conclusion [idcn]    
Hyperglycaemia [dsyn]    
Promote [acty]    
Cancer [neop]    
Attenuate [qlco]    
Optimal [qlco]    
glycemia [carb]    
Control [grup]    
inhibited [menp]    
Renin-angiotensin system [bdsy]    
Hydroxy [inch]    
Pathway [moft]    
